Avelox

Avelox

Dosage
400mg
Package
10 pill 20 pill 30 pill
Total price: 0.0
  • In our pharmacy, you can buy avelox without a prescription, with discreet delivery throughout the United Kingdom.
  • Avelox (moxifloxacin) is used to treat bacterial infections such as community-acquired pneumonia, acute sinusitis, exacerbations of chronic bronchitis, complicated skin and intra-abdominal infections and pelvic inflammatory disease; it is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV.
  • The usual dose for adults is 400 mg once daily (not recommended for children or adolescents under 18 years).
  • Available as 400 mg film-coated tablets for oral use and as a 400 mg/250 mL IV infusion (flexibag) for intravenous administration.
  • The drug reaches peak blood levels within about 1–3 hours and may begin to have an antibacterial effect soon after, with clinical symptom improvement often within 24–48 hours.
  • The elimination half-life is about 12 hours, allowing effective once-daily dosing and roughly 24 hours of activity per dose.
  • Avoid alcohol while taking avelox, as alcohol can increase side effects such as dizziness and may impede recovery.
  • The most common side effect is nausea (other frequent effects include diarrhoea, headache and dizziness).
  • Would you like to try avelox without a prescription?
Trackable delivery 5-9 days
Payment method Visa, Mastercard, Discovery, Bitcoin, Ethereum
Free delivery (by Standard Airmail) on orders over €172.19

Avelox

Basic Avelox Information

  • INN (International Nonproprietary Name): Moxifloxacin
  • Brand Names Available In United Kingdom: Avelox — 400 mg film-coated tablets
  • ATC Code: J01MA14; Classification: Systemic antibacterial, fluoroquinolone class
  • Forms & Dosages: Film-coated tablet 400 mg (oral); IV solution/flexibag 400 mg/250 mL (intravenous infusion)
  • Manufacturers In United Kingdom: not specified
  • Registration Status In United Kingdom: Approved by the MHRA; prescription-only (Rx)
  • OTC / Rx Classification: Prescription only (Rx) in the United Kingdom

Everyday Use & Best Practices

Morning Vs Evening Dosing

Worried about when to take Avelox so it fits your day?

The usual adult dose is Avelox 400mg once daily, prescribed as a single tablet or given intravenously in hospital settings.

Choose a regular time each day that matches your routine so you remember every dose.

Many UK patients prefer taking Avelox in the morning with breakfast to make it part of their routine and to monitor side effects early in the day.

If you plan to drive, do manual work or be physically active, morning dosing can help you spot dizziness or light-headedness before a full workday.

Do not crush the tablet; swallow it whole with a full glass of water.

Taking With Or Without Meals (UK Diet Habits)

Can Avelox be taken with food?

Avelox may be taken with or without food, so it can fit into typical UK eating habits such as a breakfast with tea and milk.

If Avelox causes nausea on an empty stomach, take it with a small meal or a biscuit and tea to reduce discomfort.

Avoid taking Avelox at the same time as antacids containing aluminium or magnesium, sucralfate, iron supplements, calcium or multivitamins with zinc or calcium — separate these by 4–8 hours to preserve absorption.

In hospital, the IV form follows local protocols for administration and monitoring.

  • Quick rules — Take one 400 mg tablet once daily; swallow whole with a full glass of water.
  • Do not double up if you miss a dose.
  • Avoid antacids, iron, calcium or multivitamin supplements near the dose (4–8 hour window).
  • Complete the full course to reduce resistance.
  • MHRA note — Use only where benefits outweigh risks.
  1. Missed-dose checklist: Take the missed Avelox dose as soon as you remember unless the next dose is due soon.
  2. If it is almost time for the next dose, skip the missed dose and continue the schedule.
  3. Do not take two tablets on the same day to make up for a missed dose.

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Who must not take Avelox?

Do not use Avelox if you have a known allergy to moxifloxacin or any other quinolone antibiotic.

Avelox is contraindicated in people with a history of tendon disorders related to quinolone use and in those with myasthenia gravis.

Use caution or avoid Avelox if you have a prolonged QT interval, uncorrected hypokalaemia, severe bradycardia, heart failure or are taking other QT‑prolonging drugs.

Systemic corticosteroid use raises the risk of tendon rupture when combined with quinolones.

Activities To Limit (Driving, Work Safety)

What activities should you avoid while taking Avelox?

  • Avoid heavy manual labour, climbing or working at height during treatment and for a short period afterwards if you experience tendon pain.
  • Avoid vigorous exercise if you develop tendon discomfort or swelling.
  • If you develop dizziness, drowsiness, blurred vision, light‑headedness or convulsions, do not drive or operate heavy machinery until symptoms resolve.
  • Report any new muscle weakness if you have myasthenia gravis; quinolones can exacerbate symptoms.
Contraindications Caution / Monitoring
Allergy to moxifloxacin or quinolones Check ECG if high QT-risk; monitor potassium if low
History of quinolone-related tendon disorders Avoid concurrent systemic corticosteroids where possible
Myasthenia gravis Monitor for CNS effects and neuropathy
  • Red-flag symptoms: sudden tendon pain, persistent numbness/tingling, chest pain, fainting or severe dizziness.
  • Action: stop physical activity and seek urgent advice from your GP, 111 or A&E if severe.

Dosage & Adjustments

General Regimen (NHS Guidance)

How is Avelox dosed for adults?

The standard adult regimen is Avelox 400 mg once daily by mouth, or 400 mg/250 mL IV in hospital when required.

Typical treatment durations vary by condition: community‑acquired pneumonia 7–14 days; acute bacterial sinusitis 7–10 days; acute bacterial exacerbation of chronic bronchitis about 5 days; complicated infections may require 7–21 days with an IV to oral switch where appropriate.

Take each oral tablet whole with a full glass of water and complete the prescribed course.

Indication Usual Duration
Community‑acquired pneumonia 7–14 days
Acute bacterial sinusitis 7–10 days
Acute bacterial exacerbation of chronic bronchitis 5 days
Complicated skin/skin‑structure infections 7–21 days
Complicated intra‑abdominal infections 5–14 days

Special Cases (Elderly, Comorbidities)

Do elderly patients need a lower dose?

No routine dose reduction for elderly patients is required, but clinical monitoring is important.

Monitor older adults closely for QT prolongation, CNS effects and tendinopathy, especially with cardiovascular disease, electrolyte imbalance or interacting drugs.

Children and adolescents under 18 are not recommended to receive Avelox because of musculoskeletal risk.

Renal or hepatic impairment does not usually require dose adjustment, but assess clinical response and consider alternatives if significant comorbidity exists.

  • Checklist for elderly/comorbid monitoring — review ECG if QT-risk factors present; check electrolytes; review concomitant medicines (antiarrhythmics, diuretics, steroids).
  • Do not use Avelox in under‑18s unless specifically advised by a specialist.

User Testimonials

Positive Reports From UK Patients

What do patients say about Avelox?

Many UK patients report symptom improvement within 48–72 hours for bacterial chest infections when moxifloxacin is used appropriately and prescribed for the right indication.

Patients appreciate the once‑daily dosing and the convenience of switching from IV to oral in hospital when clinically indicated.

There are reports of Avelox clearing stubborn lower respiratory infections where other treatments failed or where culture results indicated susceptibility.

Common Challenges (Patient.info, NHS Forums)

What problems do patients commonly report?

  • Gastrointestinal upset such as nausea or diarrhoea is frequently mentioned.
  • Sleep disturbance, dizziness and transient headache are common minor complaints.
  • Some patients report tendon discomfort or concern about persistent neuropathic pain.
  • Access frustration appears on forums where prescribers avoid fluoroquinolones because of MHRA cautions.
  • Patient tips: keep a medication diary noting dose times and any new pain or numbness.
  • Report suspected adverse effects to the MHRA Yellow Card scheme and inform your prescriber promptly.
  • Pharmacy support: local chains such as Boots, LloydsPharmacy and Superdrug often provide counselling at collection.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Where can you get Avelox in the UK?

Avelox is a prescription-only medicine in the United Kingdom and is supplied via GP prescriptions at community pharmacies and by hospital pharmacies for IV use.

Reputable community chains include Boots, LloydsPharmacy and Superdrug, which dispense NHS prescriptions and private prescriptions.

Online UK-registered pharmacies can also dispense with a valid prescription; avoid international or unverified sellers and check pharmacy accreditation.

In our online pharmacy, Avelox is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Price Comparison (NHS Prescription Charge Vs Private)

How much does Avelox cost?

Cost depends on whether the item is dispensed on the NHS or privately.

In England, a standard NHS prescription charge applies unless you are exempt; in Scotland, Wales and Northern Ireland prescriptions are generally free and this affects out‑of‑pocket cost.

Private prescriptions vary by pharmacy and may include a dispensing fee plus the medication cost.

Ask your pharmacist about generic moxifloxacin options and consider NHS prepayment certificates if multiple prescriptions are needed.

Source How To Obtain Notes
NHS Pharmacy GP prescription collect from Boots, LloydsPharmacy, Superdrug Subject to NHS prescription charge rules
Hospital Pharmacy IV Avelox for admitted patients Follows local hospital protocols
Online UK-registered Pharmacy Dispense with valid prescription Verify GPhC registration and contact details
  • Pharmacy verification checklist — look for GPhC registration, a physical UK address, telephone contact and clear prescription requirements.

What’s Inside & How It Works

Ingredients Overview

What is in an Avelox tablet?

The active ingredient is moxifloxacin 400 mg per film-coated tablet for oral use.

For hospitals, the intravenous option is 400 mg/250 mL in a flexibag formulation with 0.8% NaCl for infusion.

Excipients and non-active ingredients vary by manufacturer; if you have excipient allergies, check the packaging or ask the pharmacist.

Mechanism Basics Explained Simply

How does moxifloxacin kill bacteria?

Moxifloxacin belongs to fluoroquinolones and works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication.

Blocking these enzymes prevents bacteria from copying their DNA and results in bactericidal activity against many Gram‑positive, Gram‑negative and atypical organisms commonly causing respiratory and intra‑abdominal infections.

Avelox does not treat viral infections such as colds or influenza.

Active Ingredient Form Typical Targets
Moxifloxacin 400 mg Oral tablet / IV infusion Common respiratory pathogens, some Gram‑negative and atypicals

Main Indications

Approved Uses (MHRA Listing)

For which infections is Avelox authorised?

Avelox is authorised in adults for community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, complicated skin and skin‑structure infections, complicated intra‑abdominal infections, pelvic inflammatory disease and for plague in severe settings.

The usual adult dose is 400 mg once daily with duration dependent on the condition being treated.

Off-Label Uses In UK Clinics

When might clinicians consider Avelox off-label?

UK clinicians may sometimes consider moxifloxacin for resistant infections when first-line agents are unsuitable or culture results support its use.

Antimicrobial stewardship and MHRA cautions recommend restricting fluoroquinolones where possible because of safety concerns and resistance pressure.

  • Stewardship caution: document the clinical rationale for using Avelox and seek culture/sensitivity where feasible.
  • Off‑label: limited to specialist advice for resistant or complicated infections only.
Condition Usual Dose / Duration
Community‑acquired pneumonia 400 mg once daily, 7–14 days
Acute bacterial sinusitis 400 mg once daily, 7–10 days
Complicated intra‑abdominal infection 400 mg once daily, 5–14 days

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Do food and drink affect Avelox?

Alcohol does not change how Avelox works but may increase dizziness or other CNS side effects; avoid heavy drinking while on treatment.

Typical UK tea and milk are not contra‑indicative, but antacids containing aluminium or magnesium, sucralfate, iron supplements and calcium‑containing products can reduce absorption if taken at the same time.

Separate these products from Avelox by 4–8 hours where possible to maintain absorption.

Drug Conflicts (MHRA Yellow Card Reports)

Which medicines interact seriously with Avelox?

  • Other QT‑prolonging drugs and certain antiarrhythmics (class IA and III) — co‑administration may increase risk of cardiac arrhythmia.
  • Drugs that lower potassium or magnesium, and diuretics that cause electrolyte loss, can raise QT risk.
  • Systemic corticosteroids increase tendon‑rupture risk when combined with quinolones.
  • Antacids, iron and calcium supplements interfere with absorption and should be separated from dosing.

Always tell your prescriber and pharmacist about all prescription, over‑the‑counter and herbal medicines and supplements.

  • Medicines to declare: steroids, antiarrhythmics, diuretics, iron/calcium supplements, antacids, other quinolones.
  • Reporting: report suspected adverse reactions (tendon injury, neuropathy, cardiac events) to the MHRA Yellow Card scheme.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

What does recent research say about moxifloxacin?

Recent UK and EU stewardship reports emphasise restricting fluoroquinolones like moxifloxacin because of safety signals and rising resistance patterns.

Clinical trials and comparative studies from 2022–2025 continue to show moxifloxacin is effective in certain complicated respiratory and intra‑abdominal infections and is non‑inferior to some comparator agents for selected indications.

However, meta‑analyses highlight an increased risk of severe adverse events compared with older first‑line antibiotics, reinforcing the need for targeted use only.

  • Study conclusions: effective for selected bacterial infections but with a higher profile of serious side effects versus some alternatives.
  • Guidance: use where first‑line agents are unsuitable or culture sensitivity indicates benefit.
Benefit Risk
Broad activity including atypicals; once‑daily dosing Increased risk of tendinopathy, neuropathy, QT prolongation

Practical takeaway: obtain cultures where possible, document the indication in records, monitor for tendon and neurological symptoms, and report adverse events to the Yellow Card scheme.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

What are common NHS alternatives to Avelox?

For community respiratory infections, consider amoxicillin, doxycycline or macrolides depending on likely pathogens and patient factors.

Fluoroquinolones such as levofloxacin or ciprofloxacin have similar safety concerns and are not automatically safer choices.

For skin and soft tissue infections, flucloxacillin or co‑amoxiclav are commonly used first‑line agents.

  • Amoxicillin — Pros: well tolerated and widely available; Cons: not effective for atypical organisms.
  • Doxycycline — Pros: good for atypicals; Cons: avoid in pregnancy and in children under 12 (photosensitivity).
  • Macrolides (clarithromycin) — Pros: useful when penicillin allergy; Cons: may prolong QT interval, interactions with statins.
  • Levofloxacin / Ciprofloxacin — Pros: active against certain Gram‑negatives; Cons: overlapping fluoroquinolone safety concerns.
Alternative When To Consider Key Caveat
Amoxicillin Most community chest infections where pneumococcus is likely Not active against atypicals
Doxycycline Atypical coverage or penicillin allergy Avoid in pregnancy and children

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

What is Avelox’s regulatory status in the UK?

Avelox (moxifloxacin) is approved by the MHRA and is a prescription‑only medicine in the fluoroquinolone class (ATC J01MA14).

NHS antimicrobial stewardship encourages using the narrowest effective antibiotic and documenting reasons when a second‑line agent such as a fluoroquinolone is chosen.

Safety communications from the MHRA align with international alerts about tendon risk, peripheral neuropathy and CNS effects.

Regulatory Status Reporting Channel
MHRA Approved; Prescription only (Rx) MHRA Yellow Card scheme for adverse event reporting
  • Practical steps for prescribers: check drug history, consider ECG if QT risk, counsel on red‑flag symptoms and storage.

FAQ

Common UK Patient Questions

  • Can I take Avelox if I have a history of tendon pain? — No. Previous quinolone‑related tendon disorders are a contraindication; stop and seek advice if new tendon pain develops.
  • Are prescriptions free? — It depends. England usually charges an NHS prescription fee unless exempt; Scotland, Wales and Northern Ireland generally have free prescriptions. Private prescriptions vary.
  • How soon should symptoms improve? — Many patients notice improvement within 48–72 hours for bacterial respiratory infections; contact your GP if there is no improvement.
  • Can I drink alcohol? — Moderate alcohol is not contraindicated but avoid heavy drinking as it can worsen dizziness and other CNS side effects.

When to contact NHS 111 or your GP: if you have sudden tendon pain or swelling, new numbness, severe dizziness, fainting, chest pain or signs of severe allergic reaction.

Guidelines For Proper Use

UK Pharmacist Counselling Style

What should a pharmacist tell you at collection?

Confirm the indication and duration of therapy and emphasise the once‑daily 400 mg dose and the need to complete the full course.

Advise to take each tablet whole with a full glass of water and to separate antacids, iron and calcium supplements by 4–8 hours.

Warn about tendinopathy and peripheral neuropathy signs and ask patients to stop activity and seek advice if these occur.

Review other medicines for interactions — especially steroids and QT‑prolonging drugs — and provide Yellow Card reporting information and written handouts for recall.

  • Counselling checklist — dose/duration, take with water, don’t double doses, interaction review, storage (20–25°C) and Yellow Card reporting details.

NHS Patient Support Advice

Where can patients get support?

If symptoms do not improve within the expected time, arrange GP review or contact NHS 111 for out‑of‑hours advice.

Urgent review is indicated for severe side effects, and local pharmacy minor ailment services can help with symptomatic relief.

Discuss prescription cost queries and exemptions or consider an NHS prepayment certificate in England for multiple items.

Small patient leaflet template:

  • Take one Avelox 400 mg tablet once daily with water.
  • Do not take antacids, iron, calcium or multivitamins within 4–8 hours of dose.
  • Stop activity and seek medical advice for sudden tendon pain or new numbness.
  • Report adverse effects to MHRA Yellow Card and your prescriber.

Delivery Across United Kingdom

City Region Delivery time
London Greater London 5–7 days
Birmingham West Midlands 5–7 days
Manchester Greater Manchester 5–7 days
Glasgow Scotland 5–7 days
Leeds West Yorkshire 5–7 days
Edinburgh Scotland 5–7 days
Bristol South West England 5–7 days
Cardiff Wales 5–7 days
Belfast Northern Ireland 5–7 days
Newcastle North East England 5–9 days
Southampton South East England 5–9 days
Plymouth South West England 5–9 days
Norwich East of England 5–9 days
Derby East Midlands 5–9 days